Related Experiment Video
Updated: Jan 17, 2026

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
Published on: August 2, 2024
METTL3 promotes ovarian cancer progression through YTHDF2-dependent degradation of GATA4
Di Zhao1, Mengya Li2, Peiling Li1
1Department of Gynecology and Obstetrics, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150001, China.
Abstract:
Ovarian cancer (OC) remains a highly lethal gynecological malignancy with limited therapeutic options due to its aggressive progression and therapeutic resistance. N6-methyladenosine (m6A) RNA modification has emerged as a critical regulator of tumorigenesis, but the specific mechanisms linking m6A regulators to OC progression require further clarification. Here, we report that METTL3 promotes OC progression by enhancing YTHDF2-dependent degradation of the tumor suppressor GATA4. Mechanistically, METTL3-mediated hypermethylation of GATA4 transcripts at nucleotides 1837 and 2432 promotes YTHDF2-dependent mRNA decay, thereby suppressing GATA4 expression. Pharmacological inhibition of METTL3 with STM2457 increases GATA4 abundance, and attenuates malignant phenotypes of OC. Single-cell RNA sequencing (scRNA-seq) revealed that GATA4 was markedly downregulated in granulosa cells, fibroblasts, and endothelial cells within the OC microenvironment, potentially linking its loss to aberrant epithelial-mesenchymal transition (EMT), abnormal proliferation, and stromal remodeling. In conclusion, our findings establish a METTL3-YTHDF2 regulatory axis that destabilizes GATA4 mRNA, providing novel insights into the epigenetic control of OC progression. Thus, targeting this axis may offer promising therapeutic strategies to improve outcomes for OC patients.
Insights
METTL3 promotes ovarian cancer (OC) by degrading the tumor suppressor GATA4. Inhibiting METTL3 restores GATA4, reducing OC malignancy and offering new therapeutic strategies.
Area of Science:
- Oncology
- Epigenetics
- RNA Biology
Background:
- Ovarian cancer (OC) is a lethal gynecological malignancy with poor therapeutic outcomes.
- N6-methyladenosine (m6A) RNA modification is implicated in tumorigenesis, but its role in OC requires elucidation.
Purpose of the Study:
- To investigate the role of METTL3 in OC progression.
- To elucidate the molecular mechanisms by which METTL3 influences OC development.
Main Methods:
- Investigated the interaction between METTL3, YTHDF2, and GATA4 in OC cells.
- Utilized pharmacological inhibition of METTL3 (STM2457) and single-cell RNA sequencing (scRNA-seq).
Main Results:
- METTL3 promotes OC progression by mediating GATA4 mRNA degradation via YTHDF2.
- METTL3-induced GATA4 suppression is linked to aberrant EMT, proliferation, and stromal remodeling in the OC microenvironment.
- Pharmacological inhibition of METTL3 increased GATA4 levels and attenuated OC phenotypes.
Conclusions:
- A novel METTL3-YTHDF2 regulatory axis destabilizes GATA4 mRNA, driving OC progression.
- Targeting this axis presents a potential therapeutic strategy for ovarian cancer.
More Related Videos
10:32Combined Use of Tail Vein Metastasis Assays and Real-Time In Vivo Imaging to Quantify Breast Cancer Metastatic Colonization and Burden in the Lungs
Published on: December 19, 2019
09:08Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer
Published on: January 12, 2020
Related Concept Videos
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Epigenetic Regulation
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...